Dr. Alan Rodney, MD
What this data tells you about Dr. Rodney
Dr. Alan Rodney is a hematology & oncology in Webster, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rodney performed 36,838 Medicare services across 1,371 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rodney received a total of $495,872 from 71 pharmaceutical and/or device companies across 863 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 26,010 | $0 | $5 |
| Iron sucrose injection (Venofer) | 5,900 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 2,083 | $0 | $3 |
| Blood draw (venipuncture) | 586 | $8 | $20 |
| Complete blood count (CBC) with differential | 579 | $7 | $36 |
| Comprehensive metabolic blood panel | 254 | $10 | $64 |
| Office visit, established patient (30-39 min) | 245 | $95 | $368 |
| Office visit, established patient (20-29 min) | 194 | $69 | $250 |
| Basic metabolic blood panel | 157 | $8 | $49 |
| Lactate dehydrogenase (enzyme) level | 146 | $6 | $31 |
| Injection, zoledronic acid, 1 mg | 121 | $7 | $431 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 111 | $51 | $313 |
| Red blood count automated, with additional calculations | 76 | $5 | $26 |
| Reticulated (young) platelet measurement | 75 | $34 | $143 |
| Hospital follow-up visit, high complexity | 59 | $91 | $357 |
| Drug injection, under skin or into muscle | 53 | $11 | $96 |
| Administration of chemotherapy into vein, 1 hour or less | 43 | $102 | $707 |
| Liver function blood test panel | 36 | $7 | $48 |
| New patient office visit (45-59 min) | 21 | $130 | $565 |
| Ct scan of chest with contrast | 18 | $56 | $821 |
| New patient office visit (30-44 min) | 18 | $90 | $372 |
| Initial hospital admission, moderate complexity | 15 | $97 | $470 |
| CT scan of abdomen and pelvis with contrast | 14 | $187 | $1,067 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 12 | $23 | $157 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | $90 | $657 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rodney is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rodney experienced with iron infusion (feraheme)?
Does Dr. Rodney receive payments from pharmaceutical companies?
How do Dr. Rodney's costs compare to other hematology & oncologys in Webster?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology